Last updated: April 24, 2026
AU2015261630 (Australia) Drug Patent: Scope, Claims, and Landscape
What does AU2015261630 cover?
AU2015261630 is an Australian patent application published as AU2015261630A1 (priority originating from earlier filings outside Australia is not determinable from the provided record in this chat). The application is classified as a “drug” matter, but the exact drug name, active ingredient, formulations, and target indication are not present in the information available in this session.
Because claim construction and landscape mapping require the actual text of the specification and claims, and those texts are not included here, a complete and accurate scope and claims analysis for AU2015261630 cannot be produced from the available inputs.
What are the independent claims and what is the claim scope?
A claim-scope analysis requires:
- The independent claim set (typically claim 1, claim 10, claim 15, etc.)
- The defined technical features (chemical structure or generics, routes of administration, dosage ranges, polymorph definitions, salts, solvates, crystal forms, process steps)
- Any dependent claim variations that narrow or broaden coverage
No claim text, numbering, or feature set is available in this chat. Without it, any description would be speculative and would not meet an accuracy standard for legal and investment use.
What does the patent landscape look like in Australia for this drug?
A credible AU landscape requires, at minimum:
- Identifying the listed active ingredient and indication
- Mapping:
- Competing patents with overlapping claim features
- WO and EP family members entering Australia
- Patent term, priority dates, and expiry for each relevant family
- Whether any patents are linked to:
- PBS listing status
- TGA registration
- biologics vs small molecule categorization affecting enforcement patterns
No active ingredient or claim feature set is available, so landscape scoring across Australian filings and likely competitors cannot be completed.
Operational implications for R&D and investment
With no claim-feature text and no identified active ingredient, there is no defensible way to:
- Estimate enforceable subject matter in Australia
- Assess freedom-to-operate exposure
- Score likelihood of infringement under plausible generic or reformulation pathways
- Determine which prior art and claim amendments likely control validity outcomes
What can be stated with proof from this chat?
- The request is specifically for AU2015261630.
- No publication number variant (A1/AU grant), claim text, bibliographic fields, or drug identity is present here.
- Therefore, a complete scope-and-claims report and an Australia-focused patent landscape report cannot be produced accurately.
Key Takeaways
- AU2015261630 can be analyzed for scope and claim strength only using the actual specification and claim text, which is not present in this session.
- Without the identified drug substance and claim-defining features, an Australia patent landscape analysis would be speculative and not suitable for high-stakes decisions.
FAQs
1) What information is necessary to analyze AU2015261630 claim scope accurately?
The patent specification and claims text (including independent and dependent claims) plus the defined drug identity and embodiments.
2) Can an Australia patent landscape be mapped without the active ingredient?
No. A landscape needs the drug substance, formulation concepts, and indication to match competing filings and families.
3) Does AU2015261630 typically include composition and method claims?
This varies by application. The answer requires the claim set from AU2015261630 itself.
4) Can I infer scope from publication numbers alone?
No. Publication numbers do not provide the claim-defining technical features required for a correct scope analysis.
5) What does “drug patent landscape” mean for Australia practice?
It means mapping competing Australian and family members’ claims around the same active ingredient, dosing/formulation concepts, and any regulatory-linked enforceability events.
References
[1] Australian Patent Office. AU2015261630 (publication details not provided in this chat).
